The Cabinet has approved the second phase of the Vibrant Villages Programme (VVP) with an outlay of Rs 7,000 crore for the ...
3d
Clinical Trials Arena on MSNVaxcyte stock sinks despite Phase II IPD vaccine trial successVaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting ...
The park is currently in phase two of a master plan that seeks to revitalize all 53 acres of Sarasota's bayfront.
It has taken several years, and a lot of maneuvering, but the MLB-mandated improvements to 67-year old Avista Stadium are complete. There is still a wish list of things the Spokane Indians ...
Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...
2d
GlobalData on MSNCerevance to proceed with Phase III Parkinson’s trial despite Phase II setbackThe pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...
BioSciences announced the first patient has been dosed in the Phase 2 ASCEND study of PCRX-201 for the treatment of ...
Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage ...
Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...
Vaxcyte (PCVX) shared topline results from its Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, ...
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results